We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Incorporate Risk-Based Monitoring Into Trial Protocols
FDA: Incorporate Risk-Based Monitoring Into Trial Protocols
November 10, 2014
The FDA is working on a number of projects designed to lower clinical trial costs and speed up trial times, a top FDA official told conference-goers at the Society for Clinical Research Sites’ 2014 Site Solutions Summit.